Jonathan Mark Hopper, Chief Medical Officer at Vericel Corporation (VCEL), has filed 43 Form 4 transactions over the past two years, all concentrated in a single stock. The pattern is unambiguous: Hopper has never made an open-market purchase, with zero buy value recorded, while his total open-market sales reached $1.92 million. Every sale was paired with an option exercise (code M) on the same date, indicating a mechanical sell-to-cover strategy rather than discretionary portfolio shifts. The most recent cluster, spanning June 2026, shows three sales—$225,000 on June 26, $153,125 on June 2, and $121,520 on April 2—each immediately following option exercises of $149,100, $72,887.50, and $38,018.40 respectively.
The transaction cadence is regular and predictable, with sales occurring roughly quarterly: December 2025 ($64,659), September 2025 ($357,700), and March 2025 ($495,300). The dollar amounts fluctuate with the underlying stock price, but the structure remains consistent—exercise options, sell shares, and pay the tax liability. Notably, there are no outright gifts (code G) or conversions (code C) in the record, and the only non-sale activity consists of routine compensation grants (code A) and tax-withholding forfeitures (code F). The February 2026 filings show a typical vesting cycle: two zero-value grants on February 19, followed by multiple option exercises and tax withholdings on February 24.
The data reveals a straightforward insider profile: a senior executive who accumulates equity through compensation, exercises options on a schedule, and sells a portion to monetize. There is no evidence of opportunistic timing—no sales clustered around earnings announcements or clinical trial readouts. The absence of any open-market purchases, combined with the consistent sell-to-cover pattern, suggests Hopper treats his VCEL holdings as compensation to be liquidated systematically rather than as a long-term investment position. His total realized value of $1.92 million across 43 filings represents a steady, low-frequency monetization of vested equity.
AI-assisted summary